Bestar Pharmaceutical

Founded in 2010, Bestar (Shanghai) Pharmaceutical Technology Co., Ltd. is an international clinical development organization for innovative drugs. It has been awarded the title of High-tech Enterprise by the Shanghai Municipal Science and Technology Commission twice consecutively. Its services cover multiple central cities and regions across the country. It has a wholly-owned subsidiary Shangrui, and holding subsidiaries in the United States and Australia, with over a thousand employees. The company has a senior professional research team, and its main researchers all have work experience in drug R&D and clinical research departments of foreign pharmaceutical companies. It has an internationalized, standardized business operation process and a scientific and rigorous quality assurance system, and is proficient in the operation and management of international multi-center clinical trials and various types of domestic clinical trial projects. The company is headquartered in Shanghai, with branches in Beijing, Nanjing, Guangzhou, Chengdu, and Wuhan, and liaison offices and QA offices in Boston, USA, and Sydney, Australia.
Bestar's business scope includes the design, organization, operation, and management of clinical trials, such as the planning and preparation, protocol writing, site selection, clinical monitoring services, drug management, data management and biostatistics, and clinical study report writing for Phase I-IV drug clinical trials and medical device clinical trial projects. The company also provides drug and medical device registration, medical consultation and agency services, epidemiological observational studies, pharmaceutical market research, and training for investigators, CRAs, and other clinical research professionals. Innovative drug R&D includes the screening of compounds and macromolecular biological products, the synthesis and formulation of active pharmaceutical ingredients, the domestic translation of foreign patented technologies for chemical drugs and biological products, and corresponding clinical development.
In addition, Bestar has a large network of expert resources in clinical medicine, clinical pharmacology, and biostatistics, and continuously expands this network through high-quality personnel and project training of various types, thereby ensuring the rapid and high-quality completion of various clinical projects.
The company's cooperative clients include well-known multinational pharmaceutical companies and medical device enterprises, domestic research-based pharmaceutical companies, pharmaceutical research institutes, and professional academic organizations.